EGFR gene amplification and overexpression are frequent in several cancer types, including lung adenocarcinomas, colon carcinomas, and pancreatic adenocarcinomas (Sigismund et al., 2018). This evidence concerns the gene EGFR and pancreatic adenocarcinoma.